ROL Stock Analysis: Rollins | NYSE
Personal Services | NYSE, USA | Market Cap: 16.989m USD | 12M Return: -37.8% | US7757111049 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 252M
EPS Trend: 98.7%
Qual. Beats: 0
Rev. Trend: 99.9%
Qual. Beats: -2
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Rollins, Inc. (ROL) is a leading provider of pest and wildlife control services, operating primarily in the United States with international exposure. The company serves both residential and commercial customers through direct operations and franchisees, offering pest control, termite protection, and ancillary services across key end markets including healthcare, food service, and logistics. Headquartered in Atlanta, Georgia, Rollins has roots dating back to 1901 and adopted its current name in 1965.
As a constituent of the Environmental & Facilities Services sub-industry within the GICS Industrials sector, Rollins operates within a defensive services industry characterized largely by recurring, contract-based revenue streams. The pest control industry tends to benefit from stable demand driven by regulatory requirements (particularly in food-related and healthcare end markets), seasonal pest cycles, and the essential nature of infestation management for both households and businesses.
- Acquisitions accelerate pest control consolidation and route density growth
- Commercial segment expands across healthcare and food service end markets
- Pricing actions and route efficiency expand operating margins
| Net Income: 526.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.20 > 0.02 and ΔFCF/TA -0.96 > 1.0 |
| NWC/Revenue: -9.37% < 20% (prev -4.41%; Δ -4.97% < -1%) |
| CFO/TA 0.21 > 3% & CFO 697.5m > Net Income 526.1m |
| Net Debt (1.41b) to EBITDA (861.4m): 1.64 < 3 |
| Current Ratio: 0.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (479.0m) vs 12m ago -1.17% < -2% |
| Gross Margin: 42.32% > 18% (prev 52.86%; Δ -10.54% > 0.5%) |
| Asset Turnover: 121.2% > 50% (prev 114.3%; Δ 6.92% > 0%) |
| Interest Coverage Ratio: 20.10 > 6 (EBIT TTM 730.5m / Interest Expense TTM 36.4m) |
| A: -0.11 (Total Current Assets 612.8m - Total Current Liabilities 986.6m) / Total Assets 3.36b |
| B: 0.22 (Retained Earnings 748.8m / Total Assets 3.36b) |
| C: 0.22 (EBIT TTM 730.5m / Avg Total Assets 3.29b) |
| D: 0.71 (Book Value of Equity 1.39b / Total Liabilities 1.97b) |
| Altman-Z'' = 2.23 = BBB |
| DSRI: 0.99 (Receivables 304.7m/282.8m, Revenue 3.99b/3.68b) |
| GMI: 1.25 (GM 52.86% / 42.32%) |
| AQI: 1.01 (AQ_t 0.67 / AQ_t-1 0.66) |
| SGI: 1.08 (Revenue 3.99b / 3.68b) |
| TATA: -0.05 (NI 526.1m - CFO 697.5m) / TA 3.36b) |
| Beneish M = -2.74 (Cap -4..+1) = A |
As of October 24, 2026, the stock is trading at USD 34.82 with a total of 8,952,678 shares traded. Over the past week, the price has changed by +4.10%, over one month by +7.17%, over three months by -11.29% and over the past year by -37.80%.
Current recommended Stop Loss: 33.40 (which is 4.1% or 1.3 ATR below the current price).
Rollins has received a consensus analysts rating of 3.47. Therefore, it is recommended to hold ROL.
- StrongBuy: 5
- Buy: 2
- Hold: 10
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 39.8 | 14.4% |
P/E Trailing = 30.7044
P/E Forward = 25.9067
P/S = 4.3296
P/B = 11.0594
P/EG = 2.6402
Revenue TTM = 3.99b USD
EBIT TTM = 730.5m USD
EBITDA TTM = 861.4m USD
Long Term Debt = 486.1m USD (from longTermDebt, last fiscal year)
Short Term Debt = 376.7m USD (from shortTermDebt, last quarter)
Debt = 1.54b USD (from shortLongTermDebtTotal, last quarter) + Leases 412.3m
Net Debt = 1.41b USD (calculated: Debt 1.54b - CCE 129.1m)
Enterprise Value = 18.4b USD (17.0b + Debt 1.54b - CCE 129.1m)
Interest Coverage Ratio = 20.10 (Ebit TTM 730.5m / Interest Expense TTM 36.4m)
EV/FCF = 27.39x (Enterprise Value 18.4b / FCF TTM 671.8m)
FCF Yield = 3.65% (FCF TTM 671.8m / Enterprise Value 18.4b)
FCF Margin = 16.85% (FCF TTM 671.8m / Revenue TTM 3.99b)
Net Margin = 13.19% (Net Income TTM 526.1m / Revenue TTM 3.99b)
Gross Margin = 42.32% ((Revenue TTM 3.99b - Cost of Revenue TTM 2.30b) / Revenue TTM)
Gross Margin QoQ = 20.45% (prev 52.84%)
Tobins Q-Ratio = 5.48 (Enterprise Value 18.4b / Total Assets 3.36b)
Interest Expense / Debt = 2.36% (Interest Expense 36.4m / Debt 1.54b)
Taxrate = 24.21% (168.0m / 694.1m)
NOPAT = 553.7m (EBIT 730.5m * (1 - 24.21%))
Current Ratio = 0.62 (Total Current Assets 612.8m / Total Current Liabilities 986.6m)
Debt / Equity = 1.11 (Debt 1.54b / totalStockholderEquity, last quarter 1.39b)
Debt / EBITDA = 1.64 (Net Debt 1.41b / EBITDA 861.4m)
Debt / FCF = 2.10 (Net Debt 1.41b / FCF TTM 671.8m)
Total Stockholder Equity = 1.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.00% (Net Income 526.1m / Total Assets 3.36b)
RoE = 37.74% (Net Income TTM 526.1m / Total Stockholder Equity 1.39b)
RoCE = 38.85% (EBIT 730.5m / Capital Employed (Equity 1.39b + L.T.Debt 486.1m))
RoIC = 21.13% (NOPAT 553.7m / Invested Capital 2.62b)
WACC = 5.22% (E(17.0b)/V(18.5b) * Re(5.53%) + D(1.54b)/V(18.5b) * Rd(2.36%) * (1-Tc(0.24)))
Discount Rate = 5.53% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -84.15 | Cagr: -0.50%
[DCF] Terminal Value 75.38% ; FCFF base≈673.1m ; Y1≈673.2m ; Y5≈707.6m
[DCF] Fair Price = 19.96 (EV 11.0b - Net Debt 1.41b = Equity 9.61b / Shares 481.1m; r=8.35% [WACC [floored]]; 5y FCF grow -0.47% → 2.50% )
EPS Correlation: 98.67 | EPS CAGR: 10.36% | SUE: -0.82 | # QB: 0
Revenue Correlation: 99.87 | Revenue CAGR: 10.18% | SUE: -1.42 | # QB: -2
EPS current Quarter (2027-03-31): EPS=0.24 | Chg30d=-1.45% | Revisions=-50% | Analysts=11
EPS current Year (2026-12-31): EPS=1.16 | Chg30d=-1.01% | Revisions=-62% | GrowthEPS=+3.5% | GrowthRev=+8.5%
EPS next Year (2027-12-31): EPS=1.27 | Chg30d=-2.08% | Revisions=-55% | GrowthEPS=+9.8% | GrowthRev=+8.4%
[Analyst] Revisions Ratio: -74% (up=1, down=15)